How GLP-1s Support Heart Health in Patients with Type 2 Diabetes

How GLP-1s Support Heart Health in Patients with Type 2 Diabetes

Type 2 diabetes doesn’t just impact blood sugar—it significantly increases the risk of cardiovascular disease (CVD), including heart attacks, strokes, and heart failure. In fact, people with diabetes are twice as likely to develop heart disease compared to those without it.

Fortunately, newer diabetes medications like GLP-1 receptor agonists (GLP-1s) offer more than just blood sugar control—they provide meaningful cardiovascular benefits. Drugs like Ozempic (semaglutide), Wegovy (semaglutide for weight loss), and Mounjaro (tirzepatide) are now being recognized for their ability to reduce heart risks in patients with Type 2 diabetes.

This article explains how GLP-1s support cardiovascular health, what the latest research says, and how Americans can save money by ordering these medications from Canada through services like Over the Border Meds.

🫀 The Link Between Type 2 Diabetes and Heart Disease

Diabetes increases cardiovascular risk by:

  • Damaging blood vessels and arteries

  • Raising LDL (bad) cholesterol

  • Increasing inflammation and insulin resistance

  • Causing weight gain and high blood pressure

Because of this, managing heart health is a critical part of diabetes care. That’s where GLP-1 receptor agonists step in.

Mounjaro Kwikpen boxes

mounjaro kwikpen for $599.99

Shop Now

What Are GLP-1 Receptor Agonists?

 

GLP-1s are a class of injectable (and in some cases, oral) medications that:

  • Stimulate insulin secretion

  • Suppress glucagon

  • Slow gastric emptying

  • Reduce appetite and promote weight loss

But beyond these effects, GLP-1s have also been shown to lower the risk of major cardiovascular events in people with diabetes.

2 Ozempic boxes

What the Studies Say: Cardiovascular Benefits of GLP-1s

 

✅ SUSTAIN-6 (Ozempic)

This trial showed that semaglutide reduced the risk of major adverse cardiovascular events (MACE) by 26% in people with Type 2 diabetes and high cardiovascular risk.

✅ LEADER (Victoza)

Liraglutide (another GLP-1) also demonstrated a 13% reduction in MACE, including heart attacks and strokes.

✅ REWIND (Trulicity)

Trulicity (dulaglutide) showed cardiovascular benefits even in patients without established heart disease, highlighting its potential for broader use.

These findings led the American Diabetes Association and cardiology societies to recommend GLP-1s with proven CV benefit for people with diabetes and heart disease.

🧬 How Do GLP-1s Help the Heart?

 

GLP-1s support cardiovascular health through multiple mechanisms:

  • Weight loss: Even a 5–10% reduction lowers blood pressure and improves cholesterol

  • Lower blood pressure: GLP-1s can reduce systolic pressure by 2–5 mmHg

  • Improved endothelial function: Better blood vessel elasticity and reduced inflammation

  • Anti-inflammatory effects: Lower levels of markers like CRP

  • Reduced atherosclerosis progression

The overall effect is a reduced risk of heart attack, stroke, and CV-related death.

Why Americans Are Turning to Canada for GLP-1s

 

Despite their benefits, GLP-1s are shockingly expensive in the U.S.:

  • Ozempic: $1,200+/month

  • Wegovy: $1,400+/month

  • Mounjaro: $1,100+/month

  • Rybelsus (oral semaglutide): $900+/month

Insurance coverage is inconsistent, and many patients are left paying out of pocket. That’s why more Americans are choosing to order their GLP-1 prescriptions from Canada, where prices are dramatically lower.

GLP-1 Pricing in Canada (via Over the Border Meds)

 

MedicationU.S. Price (avg)Canada (Over the Border Meds)
Ozempic 1 mg$1,200+~$419 USD
Wegovy 2.4 mg$1,400+~$499 USD
Mounjaro 12.5 mg$1,100+~$752 USD
Rybelsus 14 mg$900+~$295 USD

You can legally import a 90-day supply for personal use with a valid U.S. prescription. Orders are shipped directly to your home—no insurance required.

👉 Visit Over the Border Meds to learn more.

💬 FAQs About GLP-1s and Heart Health

 

1. Can GLP-1s be used in patients without heart disease?

Yes. Newer studies like REWIND and SELECT show that GLP-1s can prevent cardiovascular events in people at risk of heart disease, even without a history of heart attack or stroke.

2. Is Wegovy approved for heart protection in people without diabetes?

Yes. In 2023, the SELECT trial showed that Wegovy reduced cardiovascular risk in overweight patients without diabetes. This marks the first time a weight loss drug has shown clear heart benefits in this population.

3. Which GLP-1 is best for heart health?

Ozempic, Wegovy, and Trulicity have the most evidence supporting cardiovascular benefit. Mounjaro is still being studied in ongoing trials like SURPASS-CVOT.

4. Are these medications safe for older adults with heart disease?

Yes, but dosing should be done carefully, especially in patients with kidney issues or those on multiple medications. Always consult your healthcare provider.

5. How can I get these medications if my insurance won’t cover them?

You can legally order from Canada through services like Over the Border Meds, which offers:

  • Brand-name medications

  • Licensed Canadian pharmacy partners

  • Discount coupon code: Hello10 (for 10% off first order)

Final Thoughts

 

GLP-1 receptor agonists are no longer just diabetes medications—they’re now part of a growing strategy to protect the heart, reduce stroke risk, and support long-term health in people with Type 2 diabetes.

If you’re struggling to afford GLP-1 medications in the U.S., buying from Canada through Over the Border Meds may be the most cost-effective and safe solution. With savings of up to 60% and direct shipping to your home, it’s never been easier to access medications that support both your blood sugar and your heart.

📌 Learn more or place your order today at Over the Border Meds